<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>HPL therapeutic design &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/hpl-therapeutic-design/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 17 Oct 2025 16:15:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>HPL therapeutic design &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Designing a Macromolecule to Combat Inflammation and Endotoxaemia</title>
		<link>https://bioengineer.org/designing-a-macromolecule-to-combat-inflammation-and-endotoxaemia/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 17 Oct 2025 16:15:16 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[anti-inflammatory macromolecule]]></category>
		<category><![CDATA[endotoxaemia treatment]]></category>
		<category><![CDATA[HPL therapeutic design]]></category>
		<category><![CDATA[IL-6/JAK2/STAT3 pathway inhibition]]></category>
		<category><![CDATA[JAK2/STAT3 pathway inhibition]]></category>
		<category><![CDATA[macromolecular engineering]]></category>
		<category><![CDATA[micelle-based drug delivery]]></category>
		<guid isPermaLink="false">https://bioengineer.org/designing-a-macromolecule-to-combat-inflammation-and-endotoxaemia/</guid>

					<description><![CDATA[In the realm of biomedical research, the quest for effective and safe anti-inflammatory therapies has never been more critical. Chronic inflammation is a precursor to numerous diseases, igniting a fervent interest in new treatment modalities. Recent studies have unveiled a compelling anti-inflammatory macromolecule known as HPL, which functions through a sophisticated mechanism to quell inflammation [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">282913</post-id>	</item>
	</channel>
</rss>
